Bibliographic Details
| Title: |
Corrigendum to 'Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?': [Annals of Oncology. Volume 37, Issue 2, February 2026, Pages 133-135]. |
| Authors: |
O'Meara TA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Burstein HJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. Electronic address: Hal_burstein@dfci.harvard.edu. |
| Source: |
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Apr 07. Date of Electronic Publication: 2026 Apr 07. |
| Publication Type: |
Published Erratum |
| Journal Info: |
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
